HeyJaredManasi Talwadekar
- Indexed articles, last 90 days
- 55
- Latest publication
- Sep 18, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
High-Dose Probiotic Helps Patients With Chronic Diarrhea (opens the original)
Read excerpt
A high-dose eight-strain probiotic formulation taken for 3 weeks was well tolerated and resulted in a reduction in the percentage of fecal primary bile acids, particularly chenodeoxycholic acid, along with changes in gut microbiome composition, among patients with bile acid malabsorption. “[The] study demonstrated promising preliminary data in improving biochemical parameters among individuals with BAM [bile acid malabsorption],” the authors of the study wrote. “Future research with a larger sam
Pancreatic Cancer Referral Rate Low in Diabetes, Weight Loss (opens the original)
Read excerpt
Among adults aged 60 years or older with new-onset diabetes and unexplained weight loss, only about a quarter had referrals for suspected pancreatic cancer and only 10.0% underwent abdominal imaging. "[The] study demonstrated opportunities to improve referral rates for people with NOD [new-onset diabetes] and weight loss. It suggested potential underutilisation of NICE [National Institute for Health and Care Excellence] referral guidelines and a possible gap in care and data quality," the resear
Oseltamivir May Cut ICU Admission Risk in Kids With Flu (opens the original)
Read excerpt
In children hospitalized with laboratory-confirmed influenza, oseltamivir treatment was associated with a reduced risk for ICU admissions and shorter hospital stays compared with no treatment. “[The study] findings suggest that healthcare professionals should encourage caregivers of children to seek care early in the course of influenza-like illness and also urgently consider oseltamivir treatment for all children and adolescents hospitalized with suspected or confirmed influenza,” the authors w
Central Obesity Reveals Hidden Risk in Overweight (opens the original)
Read excerpt
Combining central obesity measures with BMI improved multimorbidity risk identification in adults with overweight; carrying both general excess weight and extra abdominal fat together carried the biggest health risk. Hypertension and malignant cancer emerged as the most common initial chronic conditions across adiposity categories. “Incorporating a simple central obesity measure alongside BMI has the potential to improve early identification of at-risk individuals and more accurately capture the
Anifrolumab vs Belimumab in Lowering SLE Cardiovascular Risk (opens the original)
Read excerpt
In patients with systemic lupus erythematosus (SLE), anifrolumab was associated with a lower risk for major adverse cardiovascular events (MACE) than belimumab, as well as lower risks for myocardial infarction, heart failure, and ischemic stroke. “[The study] findings suggest a decreased CVD risk with anifrolumab treatment compared to belimumab in patients with SLE, which may support anifrolumab’s consideration as a safe therapeutic option, particularly for patient populations with increased CVD
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.